Semanteon Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-21,234
Closed -$197K – 256
2023
Q4
$197K Buy
+21,234
New +$174K 0.13% 203

Other funds holding HCAT

Semanteon Capital Management's HCAT Position: Q1 2024 in Review

Semanteon Capital Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 21,234 shares — an estimated $197K sold.

Semanteon Capital Management first reported a position in HCAT in Q4 2023 and held it in 1 quarter. The position peaked at $197K in Q4 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Semanteon Capital Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 21,234 Health Catalyst shares in Q1 2024, an estimated $197K.
  • Semanteon Capital Management first reported a position in Health Catalyst in Q4 2023 and held it in 1 quarter.
  • Semanteon Capital Management's Health Catalyst position peaked at $197K in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Semanteon Capital Management's 13F filing for Q1 2024, filed 30 Apr 2024.